Orphan drugs used for treatment in pediatric patients in the slovak republic
By: T. Foltánová, M. Konečný, A. Hlavatá, K. Štepánková and F. Cisárik
Open Access
|Jun 2012References
- Orphan drugs and rare diseases at glance Available at
- Hoppu, K.: Paediatric clinical pharmacology - at the beginning of new era, Eur J Clin Pharmacol, 2008, 64, p. 201-205
- Regulation (EC) No 141/2000 of the European parliament and of the council. Off J Eur Commun, 43, 2000, L18, p. 1-5.
- Regulation (EC) No 847/2000, Off J EurCommun, 43, 2000, L103, p. 5-8.
- Regulation (EC) No 1901/2006 of the European Parliament and of the Council;on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004- of 12 December 2006. available at
- The Ministry of Health Slovakia Website.
- WESTERMARK, K. et al.: European regulation on orphan medicinal products: 10 years of experience and future perspectives. Nature Rev Drug Discov. 2011;10:341-349
- KUŽELOVÁ, M.: Does European "orphan" medicinal products legislation help to treat children suffering from rare diseases? (in slovak) Pediatria pre prax. 8, 5, 2007, p. 260-262
- KUŽELOVÁ, M. - REPICKÁ, L. - ONDRIAŠOVÁ, E. - KOVÁCSOVÁ, B. - MAZÁG, J. -FOLTÁNOVÁ, T.: Is early treatment of patients with rare diseases in Slovak republic really available? (in slovak) Farm Obzor, 79, 8, 2010, p. 223-227.
- The State Institute for Drug Control Website
DOI: https://doi.org/10.2478/v10219-012-0001-0 | Journal eISSN: 2453-6725 (formerly 1338-6786) | Journal ISSN: 0301-2298
Language: English
Page range: 28 - 34
Published on: Jun 19, 2012
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2012 T. Foltánová, M. Konečný, A. Hlavatá, K. Štepánková, F. Cisárik, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons License.